JPMORGAN CHASE & CO - MENLO THERAPEUTICS INC ownership

MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 53 filers reported holding MENLO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of MENLO THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$667,000
-39.5%
385,405
-6.3%
0.00%
Q1 2020$1,102,000
-51.9%
411,449
-16.6%
0.00%
Q4 2019$2,289,000
-4.4%
493,149
-7.7%
0.00%
Q3 2019$2,394,000
-28.8%
534,334
-11.7%
0.00%
-100.0%
Q2 2019$3,364,000
-32.1%
605,071
-4.1%
0.00%0.0%
Q1 2019$4,951,000
+68.0%
630,716
-11.8%
0.00%0.0%
Q4 2018$2,947,000
-49.9%
715,377
+19.8%
0.00%0.0%
Q3 2018$5,879,000
+464.2%
596,959
+365.6%
0.00%
Q2 2018$1,042,000
-75.9%
128,200
+11.3%
0.00%
-100.0%
Q1 2018$4,329,000115,1850.00%
Other shareholders
MENLO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of MENLO THERAPEUTICS INC shareholders